Tanya Wildes is an Oncology physician. OpenAlex indexes 395 publications with 8,214 citations (h-index 46); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
150 Entrance Way
Saint Peters, MO 633761645
Telephone
636-996-3360Registry record last updated 29 Jan 2018.
Clinical trials
- In-Home Sensor Monitoring of Older Adults With Cancer
Sponsor: Washington University School of Medicine
- Falls Risk Questionnaire in Older Adults With Cancer
Sponsor: Washington University School of Medicine
- Geriatric Assessments in Senior Adults With Multiple Myeloma
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- Janssen Biotech, Inc.Program year20242 payments
- PFIZER INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.3%Thalidomide Analog53.3%Revlimid92%Pomalyst8%Part D<11 patientsDermatology
17.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor17.9%Acyclovir100%Part D≥21 patientsAnti-infectives
15.4%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor15.4%Valacyclovir100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2012–2024 per NIH RePORTER. The latest:
- Perioperative mental health intervention for older adults undergoing cancer surgery
Washington University
FY2024$220,784P50MH122351 - Perioperative mental health intervention for older adults undergoing cancer surgery
Washington University
FY2023$231,282P50MH122351 - Perioperative mental health intervention for older adults undergoing cancer surgery
Washington University
FY2022$240,440P50MH122351
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
Journal of Clinical Oncology
2023 - Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review
Biology of Blood and Marrow Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”